港股異動 | 宇華教育(6169.HK)續跌超8% 遭招商證券削目標價35.8%
格隆匯10月28日丨昨日大跌近20%的宇華教育(6169.HK)繼續下挫超8%,報3.51港元,總市值118億港元。10月27日公司公吿增發2.2億新股(6.5%攤薄比例),發行價為4.19港元(相比26日收盤價有12%折讓),募資金額為9.22億港元。管理層強調了銀行融資存在挑戰,因此尋求股權融資。招商證券認為宇華內部擴張及升格職業本科的投資計劃潛在限制了宇華對於併購的資金能力,而對於行業而言,併購是盈利增長和估值的重要催化劑。削公司目標價35.8%至4.3港元,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.